Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Administration of Cinacalcet in Pediatric Patients With Ckd; a Short-Review on Recent Concepts Publisher



Mojtahedi SY1 ; Pourpashang P1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Chronic Kidney Disease Research Center, Gene, Cell and Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Parathyroid Disease Published:2025


Abstract

Cinacalcet shows promise in treating secondary hyperparathyroidism (sHPT) in both pediatric and adult chronic kidney disease (CKD) populations; however, its efficacy appears more pronounced in adults. Pediatric patients face unique challenges that can hinder treatment success, necessitating careful monitoring and individualized approaches to therapy. Further research is essential to optimize dosing strategies and improve outcomes for children receiving cinacalcet. © 2025 The Author(s); Published by Nickan Research Institute.